no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Activity of Alisertib (MLN8237) as Single Agent in Recurrent Atypical Teratoid Rhabdoid Tumor (AT/RT) in Four Children: A Single Patient Treatment Plan Pilot Study
|
Wetmore, C. |
|
2014 |
207 |
9 |
p. 453- 1 p. |
article |
2 |
A gene signature for a long-term survivor of an atypical teratoid/rhabdoid tumor
|
Sredni, Simone T. |
|
2014 |
207 |
9 |
p. 420-424 5 p. |
article |
3 |
A Gene Signature to Identify Long-Survival Atypical Teratoid/Rhabdoid Tumors (AT/RT)
|
Sredni, Simone Treiger |
|
2014 |
207 |
9 |
p. 459-460 2 p. |
article |
4 |
Alterations in IGFBP7 and EGFR/AKT Pathway in SMARCB1 Deficient Tumor Cells
|
Darr, Jonatan |
|
2014 |
207 |
9 |
p. 446- 1 p. |
article |
5 |
Analysis of 57 Cases Non-Epithelioid Type Pediatric INI1-Negative Sarcomas
|
Mitrofanova, A. |
|
2014 |
207 |
9 |
p. 449- 1 p. |
article |
6 |
Analysis of the Wnt5b Signaling Pathway to Identify Novel Therapeutics for Atypical Teratoid Rhabdoid Tumors
|
Bhardwaj, R.D. |
|
2014 |
207 |
9 |
p. 451-452 2 p. |
article |
7 |
Arsenic Trioxide Inhibits Growth of Rhabdoid Cell Line KD
|
Ebinger, Martin |
|
2014 |
207 |
9 |
p. 455-456 2 p. |
article |
8 |
Arsenic Trioxide Inhibits Tumor Cell Growth in Malignant Rhabdoid Tumor Cell In Vitro and In Vivo by Targeting Overexpressed Gli1
|
Kerl, K. |
|
2014 |
207 |
9 |
p. 452- 1 p. |
article |
9 |
A SMARCB1-Deficient, Highly Penetrant Brain Tumour Mouse Model Recapitulates Human AT/RT
|
Han, Zhi-Yan |
|
2014 |
207 |
9 |
p. 451- 1 p. |
article |
10 |
Atypical Teratoid Rhabdoid Tumor (AT/RT): Improved Long-Term Survival with an Intensive Multimodal Therapy and Delayed Radiotherapy. The Medical University of Vienna Experience 1992–2012
|
Slavc, Irene |
|
2014 |
207 |
9 |
p. 459- 1 p. |
article |
11 |
Atypical Teratoid Rhabdoid Tumours (AT/RT): A French Retrospective Study
|
Bertozzi, Anne-Isabelle |
|
2014 |
207 |
9 |
p. 455- 1 p. |
article |
12 |
Case Report of a Patient With Speech Delay and Behavioral Disorders Associated with Neuroblastoma. Possible Role of SMARCA4
|
Defachelles, Anne-Sophie |
|
2014 |
207 |
9 |
p. 455- 1 p. |
article |
13 |
Characterising Critical Pathways in Malignant Rhabdoid Tumourigenesis: A Genome-Wide Analysis of Primary Tumours and Functional Genomic Models
|
Finetti, Martina |
|
2014 |
207 |
9 |
p. 447- 1 p. |
article |
14 |
Chromatin remodeling: from transcription to cancer
|
Yaniv, Moshe |
|
2014 |
207 |
9 |
p. 352-357 6 p. |
article |
15 |
Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB)
|
Bartelheim, Kerstin |
|
2014 |
207 |
9 |
p. 379-383 5 p. |
article |
16 |
Clinical Characteristics and Outcome of Children with Extracranial, Extrarenal Rhabdoid Tumors Registered to the European Rhabdoid Registry 2007–2013
|
Bartelheim, K. |
|
2014 |
207 |
9 |
p. 453-454 2 p. |
article |
17 |
CNS AT/RTs are a Heterogeneous Entity That Comprises Subgroups with Distinct Molecular Profiles
|
Johann, Pascal |
|
2014 |
207 |
9 |
p. 447- 1 p. |
article |
18 |
Conditional Inactivation of SMARCB1 in P0 Permissive Mouse Cells Generates Rhabdoid Tumors in the Peripheral Nervous System
|
Vitte, Jeremie |
|
2014 |
207 |
9 |
p. 451- 1 p. |
article |
19 |
Congenital multifocal rhabdoid tumor: a case with peculiar biological behavior and different response to treatment according to location (central nervous system and kidney)
|
Pio, Luca |
|
2014 |
207 |
9 |
p. 441-444 4 p. |
article |
20 |
Congenital Rhabdoid Tumors – Feasibility of Aggressive Multimodal Therapy in the Youngest
|
Seeringer, Angela |
|
2014 |
207 |
9 |
p. 458-459 2 p. |
article |
21 |
Cover 1
|
|
|
2014 |
207 |
9 |
p. OFC- 1 p. |
article |
22 |
Cytoplasmic Interaction of the Tumour Suppressor Protein hSNF5 with Dynamin-2 Controls Endocytosis
|
Alfonso-Perez, T. |
|
2014 |
207 |
9 |
p. 454-455 2 p. |
article |
23 |
Detection of an ATRT Brain Tumor Gene Deletion Diagnostic in Circulating Blood using Next Gen Sequencing
|
Chakravadhanula, Madhavi |
|
2014 |
207 |
9 |
p. 450- 1 p. |
article |
24 |
Durable Tumor Regression in Genetically Altered Malignant Rhabdoid Tumors by Inhibition of EZH2
|
Heike, Keilhack |
|
2014 |
207 |
9 |
p. 452-453 2 p. |
article |
25 |
Editorial Board
|
|
|
2014 |
207 |
9 |
p. A3- 1 p. |
article |
26 |
Effect of Telomerase Inhibition on Preclinical Models of Malignant Rhabdoid Tumor
|
Hu, Yafang |
|
2014 |
207 |
9 |
p. 452- 1 p. |
article |
27 |
Effect of telomerase inhibition on preclinical models of malignant rhabdoid tumor
|
Hu, Yafang |
|
2014 |
207 |
9 |
p. 403-411 9 p. |
article |
28 |
Expression of Mutant SMARCB1 Proteins in Schwannomas of Schwannomatosis Patients
|
Hulsebos, Theo |
|
2014 |
207 |
9 |
p. 450-451 2 p. |
article |
29 |
Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors
|
Chakravadhanula, Madhavi |
|
2014 |
207 |
9 |
p. 425-428 4 p. |
article |
30 |
Extra-Cranial Malignant Rhabdoid Tumor in Children: A Single Institute Experience
|
Hong, Che Ry |
|
2014 |
207 |
9 |
p. 456- 1 p. |
article |
31 |
Fatal Metachronous Supratentorial AT/RT in an Infant Successfully Treated for a Neonatal Extra-Renal non CNS-Rhabdoid Tumour INI1 Negative
|
Opocher, Enrico |
|
2014 |
207 |
9 |
p. 458- 1 p. |
article |
32 |
Genomic Alterations in Atypical Teratoid/Rhabdoid Tumors: The Medical University of Vienna Experience
|
Haberler, Christine |
|
2014 |
207 |
9 |
p. 456- 1 p. |
article |
33 |
Genomic Analysis Suggests Potential Therapeutic Targets for Atypical Teratoid/Rhabdoid Tumors (AT/RT)
|
Sredni, Simone Treiger |
|
2014 |
207 |
9 |
p. 448- 1 p. |
article |
34 |
Identifying Molecular Markers for the Sensitive Detection of Residual AT/RT Cells
|
Vu-Han, Tu-Lan |
|
2014 |
207 |
9 |
p. 449-450 2 p. |
article |
35 |
Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells
|
Vu-Han, Tu-Lan |
|
2014 |
207 |
9 |
p. 390-397 8 p. |
article |
36 |
Integrative Genomic Analyses of Atypical Teratoid Rhabdoid Tumours (ATRTs)
|
Torchia, Jonathon |
|
2014 |
207 |
9 |
p. 447-448 2 p. |
article |
37 |
Introduction from the editor
|
Biegel, Jaclyn |
|
2014 |
207 |
9 |
p. 345- 1 p. |
article |
38 |
Involvement of SMARCB1 in Inherited Predisposition to Schwannoma, Meningioma and Rhabdoid Tumours
|
Smith, Miriam J. |
|
2014 |
207 |
9 |
p. 450- 1 p. |
article |
39 |
Involvement of the SWI/SNF Complex in Familial Meningiomatosis
|
Smith, Miriam J. |
|
2014 |
207 |
9 |
p. 445- 1 p. |
article |
40 |
Loss of NOXA Expression by INI1/SNF5 Loss Impaired Sensitivity to Chemotherapeutic Agents in Malignant Rhabdoid Tumor
|
Ouchi, Kazutaka |
|
2014 |
207 |
9 |
p. 446- 1 p. |
article |
41 |
Malignant Extracranial Tumors of Childhood and Adolescence With Loss of SMARCB1/INI1 Expression
|
Leuschner, Ivo |
|
2014 |
207 |
9 |
p. 448-449 2 p. |
article |
42 |
Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion
|
Bosse, Kristopher R. |
|
2014 |
207 |
9 |
p. 415-419 5 p. |
article |
43 |
Malignant Rhabdoid Tumor of the Kidney (MRTK) – Data of 52 Patients Treated According to Protocols of the GPOH (German Society of Paediatric Oncology and Haematology)
|
Furtwängler, R. |
|
2014 |
207 |
9 |
p. 454- 1 p. |
article |
44 |
Malignant rhabdoid tumor of the kidney: significantly improved response to pre-operative treatment intensified with doxorubicin
|
Furtwängler, Rhoikos |
|
2014 |
207 |
9 |
p. 434-436 3 p. |
article |
45 |
Malignant rhabdoid tumor of the liver presented with initial tumor rupture
|
Kachanov, Denis |
|
2014 |
207 |
9 |
p. 412-414 3 p. |
article |
46 |
Malignant Rhabdoid Tumors of Soft Tissue. Single Center Experience in Russia
|
Kachanov, Denis |
|
2014 |
207 |
9 |
p. 456-457 2 p. |
article |
47 |
Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth
|
Kim, Kimberly H. |
|
2014 |
207 |
9 |
p. 365-372 8 p. |
article |
48 |
Neurocognitive Evaluation of Long Term Survivor’s Patients with AT/RT
|
Fay-McClymont, Taryn |
|
2014 |
207 |
9 |
p. 454- 1 p. |
article |
49 |
Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
|
Renard, Caroline |
|
2014 |
207 |
9 |
p. 384-389 6 p. |
article |
50 |
Non Rhabdoid Pediatric SMARCB1-Deficient Tumors: What Diagnosis, for What Treatment?
|
Renard, Caroline |
|
2014 |
207 |
9 |
p. 458- 1 p. |
article |
51 |
Pathology and diagnosis of SMARCB1-deficient tumors
|
Margol, Ashley S. |
|
2014 |
207 |
9 |
p. 358-364 7 p. |
article |
52 |
Pattern of Relapse After Radiotherapy in Children with Cerebral Atypical Teratoid and Rhabdoid Tumors (AT/RT)
|
Beneyton, V. |
|
2014 |
207 |
9 |
p. 453- 1 p. |
article |
53 |
Phosphoprotemic Analysis of Snf5 Deficient Tumor Cells Reveals Activation of EGFr Signaling Which Is Dependent Upon Snf5 Expression
|
Darr, Jonatan |
|
2014 |
207 |
9 |
p. 446- 1 p. |
article |
54 |
Prognostic Value of Clinical, Histopathological and Molecular Features in AT/RT
|
Hasselblatt, Martin |
|
2014 |
207 |
9 |
p. 449- 1 p. |
article |
55 |
Rhabdoid Tumors: Diagnostic Challenges, Multimodal Treatment and Outcome. Experience From a Single Institution Over the Last 10 Years
|
Mora, Jaume |
|
2014 |
207 |
9 |
p. 457-458 2 p. |
article |
56 |
Rhabdoid tumors: integrating biological insights with clinical success
|
Bourdeaut, Franck |
|
2014 |
207 |
9 |
p. 346-351 6 p. |
article |
57 |
Rhabdoid tumor: the Irish experience 1986–2013
|
Uwineza, Alice |
|
2014 |
207 |
9 |
p. 398-402 5 p. |
article |
58 |
Rhabdoid Tumour (RT): A Case Report with Peculiar Biological Behaviour and Results of Treatment (Tx) According to Different Location (CNS and Kidney)
|
Milanaccio, Claudia |
|
2014 |
207 |
9 |
p. 457- 1 p. |
article |
59 |
Rhabdoid Tumours of Brain, Liver, Kidney and Soft-Parts: Expression Profiles Suggest Common Features but Different Entities.
|
Richer, Wilfrid |
|
2014 |
207 |
9 |
p. 448- 1 p. |
article |
60 |
Schwannomatosis Following an Early Rhabdoid Tumour of the Kidney: The Two Conditions May Coincide
|
Verkarre, Virginie |
|
2014 |
207 |
9 |
p. 460- 1 p. |
article |
61 |
SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor
|
Bahrami, Armita |
|
2014 |
207 |
9 |
p. 437-440 4 p. |
article |
62 |
SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors
|
Smith, Miriam J. |
|
2014 |
207 |
9 |
p. 373-378 6 p. |
article |
63 |
SNF5/INI1 Deficiency Destabilizes the SWI/SNF Complex During Malignant Rhabdoid Tumor Development
|
Kuwahara, Yasumichi |
|
2014 |
207 |
9 |
p. 445- 1 p. |
article |
64 |
Successful Treatment of Malignant Rhabdoid Tumor of the Liver Presented With Initial Tumor Rupture
|
Kachanov, Denis |
|
2014 |
207 |
9 |
p. 457- 1 p. |
article |
65 |
Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor—feasibility and efficacy of multimodal therapy in a long-term survivor
|
Seeringer, Angela |
|
2014 |
207 |
9 |
p. 429-433 5 p. |
article |
66 |
Table of Contents
|
|
|
2014 |
207 |
9 |
p. A1-A2 nvt p. |
article |